{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:06:24Z","timestamp":1756512384199,"version":"3.44.0"},"reference-count":88,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780323998734"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/b978-0-323-99873-4.00022-0","type":"book-chapter","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T07:59:41Z","timestamp":1685347181000},"page":"729-747","source":"Crossref","is-referenced-by-count":0,"title":["The effect of glioblastoma microenvironment on therapeutic, diagnostic, or theranostic systems"],"prefix":"10.1016","author":[{"given":"Cl\u00e1udia","family":"Martins","sequence":"first","affiliation":[]},{"given":"Catarina","family":"Pacheco","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0010","article-title":"Immunotherapy for glioblastoma: current progress and challenges","volume":"12","author":"Yu","year":"2021","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0015","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41578-019-0135-y","article-title":"Dissecting and rebuilding the glioblastoma microenvironment with engineered materials","volume":"4","author":"Wolf","year":"2019","journal-title":"Nat Rev Mater"},{"issue":"48","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0020","doi-asserted-by":"crossref","first-page":"37716","DOI":"10.1074\/jbc.M110.161190","article-title":"Hypoxia increases the dependence of glioma cells on glutathione*","volume":"285","author":"Ogunrinu","year":"2010","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0025","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00005072-200606000-00001","article-title":"'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis","volume":"65","author":"Rong","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.molmed.2021.11.001","article-title":"Bringing vascularization into glioblastoma in vitro models","volume":"28","author":"Pacheco","year":"2021","journal-title":"Trends Mol Med"},{"issue":"5","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0035","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/cdd.2010.150","article-title":"Acidic stress promotes a glioma stem cell phenotype","volume":"18","author":"Hjelmeland","year":"2011","journal-title":"Cell Death Differ"},{"issue":"5","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5306\/wjco.v3.i5.67","article-title":"A complete compilation of matrix metalloproteinase expression in human malignant gliomas","volume":"3","author":"Hagemann","year":"2012","journal-title":"World J Clin Oncol"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2018.05.008","article-title":"Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment","volume":"281","author":"Ganipineni","year":"2018","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0050","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1021\/acsnano.6b00870","article-title":"Stimuli-responsive programmed specific targeting in nanomedicine","volume":"10","author":"Wang","year":"2016","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0055","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrc.2017.77","article-title":"Tumour acidosis: from the passenger to the driver's seat","volume":"17","author":"Corbet","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0060","article-title":"Role of endolysosomes and pH in the pathogenesis and treatment of glioblastoma","volume":"2","author":"Halcrow","year":"2019","journal-title":"Cancer Rep"},{"issue":"5","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0065","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/1568009616666151222150543","article-title":"Lactate transporters and pH regulation: potential therapeutic targets in glioblastomas","volume":"16","author":"Miranda-Gon\u00e7alves","year":"2016","journal-title":"Curr Cancer Drug Targets"},{"issue":"2","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nm0297-177","article-title":"Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation","volume":"3","author":"Helmlinger","year":"1997","journal-title":"Nat Med"},{"issue":"15","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0075","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s00018-017-2496-y","article-title":"The acidic microenvironment as a possible niche of dormant tumor cells","volume":"74","author":"Peppicelli","year":"2017","journal-title":"Cell Mol Life Sci"},{"issue":"1\u20133","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000468621","article-title":"Plasminogen activators and matrix metalloproteinases in angiogenesis","volume":"49","author":"Mignatti","year":"1996","journal-title":"Enzyme Protein"},{"issue":"1","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.radonc.2009.11.007","article-title":"Glycolytic metabolism and tumour response to fractionated irradiation","volume":"94","author":"Sattler","year":"2010","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0090","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1158\/1535-7163.MCT-06-0024","article-title":"Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics","volume":"5","author":"Gerweck","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0095","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbadis.2013.01.020","article-title":"The role of proton dynamics in the development and maintenance of multidrug resistance in cancer","volume":"1832","author":"Daniel","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1593\/neo.05697","article-title":"Impact of extracellular acidity on the activity of P-glycoprotein and the cytotoxicity of chemotherapeutic drugs","volume":"8","author":"Thews","year":"2006","journal-title":"Neoplasia"},{"issue":"11","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0105","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","article-title":"Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes","volume":"72","author":"Calcinotto","year":"2012","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0110","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell\u2013derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0115","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.4049\/jimmunol.0902584","article-title":"Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes","volume":"184","author":"Dietl","year":"2010","journal-title":"J Immunol"},{"issue":"1887","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0120","article-title":"Accomplices of the hypoxic tumor microenvironment compromising antitumor immunity: adenosine, lactate, acidosis, vascular endothelial growth factor, potassium ions, and phosphatidylserine","volume":"8","author":"Vaupel","year":"2017","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/cells6040045","article-title":"The role of hypoxia in glioblastoma invasion","volume":"6","author":"Monteiro","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00109-013-1019-z","article-title":"Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme","volume":"91","author":"Soda","year":"2013","journal-title":"J Mol Med (Berl)"},{"issue":"10","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0135","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.acra.2005.05.027","article-title":"Vessel tortuosity and brain tumor malignancy: a blinded study","volume":"12","author":"Bullitt","year":"2005","journal-title":"Acad Radiol"},{"issue":"4","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4161\/cam.4.4.12660","article-title":"The pro-migratory and pro-invasive role of the procoagulant tissue factor in malignant gliomas","volume":"4","author":"D\u00fctzmann","year":"2010","journal-title":"Cell Adhes Migr"},{"issue":"5","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0145","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4155\/fmc.13.17","article-title":"Hypoxia inducible factor pathway inhibitors as anticancer therapeutics","volume":"5","author":"Burroughs","year":"2013","journal-title":"Future Med Chem"},{"issue":"2","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0150","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI89587","article-title":"Overcoming therapeutic resistance in glioblastoma: the way forward","volume":"127","author":"Osuka","year":"2017","journal-title":"J Clin Invest"},{"issue":"45","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0155","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1038\/onc.2009.252","article-title":"Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1\u03b1","volume":"28","author":"Soeda","year":"2009","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0160","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/jcb.22956","article-title":"Hypoxia-mediated biological control","volume":"112","author":"Cassavaugh","year":"2011","journal-title":"J Cell Biochem"},{"issue":"11","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0165","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W","article-title":"Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression","volume":"88","author":"Zagzag","year":"2000","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0170","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ccr.2008.01.034","article-title":"HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion","volume":"13","author":"Du","year":"2008","journal-title":"Cancer Cell"},{"issue":"29","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0175","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.2174\/138161210793429788","article-title":"Modulation of carbonic anhydrase 9 (CA9) in human brain cancer","volume":"16","author":"Said","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0180","doi-asserted-by":"crossref","first-page":"972913","DOI":"10.1155\/2013\/972913","article-title":"Role of glutathione in cancer progression and chemoresistance","volume":"2013","author":"Traverso","year":"2013","journal-title":"Oxidative Med Cell Longev"},{"issue":"2","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0185","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/10408360500523878","article-title":"Glutathione in cancer biology and therapy","volume":"43","author":"Estrela","year":"2006","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"3\u20134","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0753-3322(03)00043-X","article-title":"The importance of glutathione in human disease","volume":"57","author":"Townsend","year":"2003","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0195","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","article-title":"Lipid peroxidation and ferroptosis: the role of GSH and GPx4","volume":"152","author":"Ursini","year":"2020","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0200","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1042\/BJ20151227","article-title":"Protein oxidation and peroxidation","volume":"473","author":"Davies","year":"2016","journal-title":"Biochem J"},{"issue":"7","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0205","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1083\/jcb.201804161","article-title":"Glutathione metabolism in cancer progression and treatment resistance","volume":"217","author":"Bansal","year":"2018","journal-title":"J Cell Biol"},{"issue":"3","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0210","article-title":"Oxidative stress and antioxidant status in high-risk prostate cancer subjects","volume":"10","author":"Shukla","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"32","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0215","doi-asserted-by":"crossref","first-page":"29330","DOI":"10.1021\/acsami.9b10211","article-title":"Mitochondria-specific anticancer drug delivery based on reduction-activated polyprodrug for enhancing the therapeutic effect of breast cancer chemotherapy","volume":"11","author":"Wang","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"issue":"8","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0220","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bcp.2011.11.016","article-title":"The role of glutathione in brain tumor drug resistance","volume":"83","author":"Backos","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0225","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/mc.22996","article-title":"Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: relevance of statins in chemosensitization","volume":"58","author":"Mallappa","year":"2019","journal-title":"Mol Carcinog"},{"issue":"10","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.465","article-title":"Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo","volume":"5","author":"Rocha","year":"2014","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/jnc.14250","article-title":"Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis","volume":"144","author":"Zhu","year":"2018","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0240","first-page":"384","article-title":"Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase a activation in human malignant brain tumors in vivo and in vitro","volume":"56","author":"Yamamoto","year":"1996","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0245","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3171\/jns.1995.83.2.0298","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas","volume":"83","author":"Nakano","year":"1995","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0250","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3171\/jns.1994.81.1.0069","article-title":"Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors","volume":"81","author":"Nakagawa","year":"1994","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0255","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling","volume":"8","author":"Page-McCaw","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0260","doi-asserted-by":"crossref","first-page":"109369","DOI":"10.1016\/j.biopha.2019.109369","article-title":"Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence","volume":"118","author":"Zhou","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0265","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1158\/1078-0432.CCR-09-0575","article-title":"Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy","volume":"15","author":"Lucio-Eterovic","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"1\u20133","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2006.05.026","article-title":"Pro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells","volume":"542","author":"Trog","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0275","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.18632\/oncotarget.683","article-title":"Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity","volume":"3","author":"Asuthkar","year":"2012","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0280","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/neuros\/nyw026","article-title":"The pluripotent stem-cell marker alkaline phosphatase is highly expressed in refractory glioblastoma with DNA hypomethylation","volume":"80","author":"Iwadate","year":"2017","journal-title":"Neurosurgery"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0285","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.2147\/CMAR.S199207","article-title":"Overexpression of the phospholipase A2 group V gene in glioma tumors is associated with poor patient prognosis","volume":"11","author":"Wu","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"10","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0290","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.7150\/thno.38069","article-title":"Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics","volume":"10","author":"Mi","year":"2020","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0295","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/nsr\/nwx062","article-title":"The acidic tumor microenvironment: a target for smart cancer nano-theranostics","volume":"5","author":"Feng","year":"2017","journal-title":"Natl Sci Rev"},{"issue":"17","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0300","doi-asserted-by":"crossref","first-page":"19345","DOI":"10.1021\/acsami.0c04102","article-title":"Tumor responsive and tunable polymeric platform for optimized delivery of paclitaxel to treat glioblastoma","volume":"12","author":"Graham-Gurysh","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0305","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2010.12.005","article-title":"Block copolymer micelles with acid-labile ortho ester side-chains: synthesis, characterization, and enhanced drug delivery to human glioma cells","volume":"151","author":"Tang","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0310","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biomaterials.2018.07.035","article-title":"Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma","volume":"181","author":"Li","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0315","doi-asserted-by":"crossref","first-page":"117907","DOI":"10.1016\/j.carbpol.2021.117907","article-title":"pH-controlled nucleolin targeted release of dual drug from chitosan-gold based aptamer functionalized nano drug delivery system for improved glioblastoma treatment","volume":"262","author":"Sathiyaseelan","year":"2021","journal-title":"Carbohydr Polym"},{"issue":"51","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0320","doi-asserted-by":"crossref","first-page":"1803717","DOI":"10.1002\/adma.201803717","article-title":"Effective and targeted human orthotopic glioblastoma xenograft therapy via a multifunctional biomimetic nanomedicine","volume":"30","author":"Zou","year":"2018","journal-title":"Adv Mater"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0325","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2017.04.033","article-title":"cRGD peptide-installed epirubicin-loaded polymeric micelles for effective targeted therapy against brain tumors","volume":"258","author":"Quader","year":"2017","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0330","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10637-016-0422-z","article-title":"A first-in-human phase 1 study of epirubicin-conjugated polymer micelles (K-912\/NC-6300) in patients with advanced or recurrent solid tumors","volume":"35","author":"Mukai","year":"2017","journal-title":"Investig New Drugs"},{"issue":"8","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0335","doi-asserted-by":"crossref","first-page":"10127","DOI":"10.1021\/acsnano.0c03386","article-title":"Translational nanomedicine boosts anti-PD1 therapy to eradicate orthotopic PTEN-negative glioblastoma","volume":"14","author":"Kinoh","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0340","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.2147\/IJN.S196959","article-title":"Hypoxia-active nanoparticles used in tumor theranostic","volume":"14","author":"Wang","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0345","doi-asserted-by":"crossref","first-page":"127359","DOI":"10.1016\/j.cej.2020.127359","article-title":"Hypoxia-degradable zwitterionic phosphorylcholine drug nanogel for enhanced drug delivery to glioblastoma","volume":"408","author":"She","year":"2021","journal-title":"Chem Eng J"},{"issue":"46","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0350","doi-asserted-by":"crossref","first-page":"1703967","DOI":"10.1002\/adfm.201703967","article-title":"Traceable nanoparticles with spatiotemporally controlled release ability for synergistic glioblastoma multiforme treatment","volume":"27","author":"Lu","year":"2017","journal-title":"Adv Funct Mater"},{"issue":"40","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0355","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1002\/smll.201601932","article-title":"Microenvironment-responsive three-pronged approach breaking traditional chemotherapy to target Cancer stem cells for synergistic inoperable large tumor therapy","volume":"12","author":"Li","year":"2016","journal-title":"Small"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0360","doi-asserted-by":"crossref","first-page":"119915","DOI":"10.1016\/j.ijpharm.2020.119915","article-title":"Hypoxia-sensitive micellar nanoparticles for co-delivery of siRNA and chemotherapeutics to overcome multi-drug resistance in tumor cells","volume":"590","author":"Joshi","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0365","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.biomaterials.2017.01.001","article-title":"Development of a hypoxia-triggered and hypoxic radiosensitized liposome as a doxorubicin carrier to promote synergetic chemo\u2212\/radio-therapy for glioma","volume":"121","author":"Liu","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0370","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2020.08.035","article-title":"Hypoxia-activated ROS burst liposomes boosted by local mild hyperthermia for photo\/chemodynamic therapy","volume":"328","author":"X-L","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0375","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.actbio.2021.07.014","article-title":"Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy","volume":"131","author":"Huang","year":"2021","journal-title":"Acta Biomater"},{"issue":"18","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0380","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.7150\/thno.26225","article-title":"Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy","volume":"8","author":"Hua","year":"2018","journal-title":"Theranostics"},{"issue":"19","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0385","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1021\/ja500962u","article-title":"Tunable heptamethine-azo dye conjugate as an NIR fluorescent probe for the selective detection of mitochondrial glutathione over cysteine and homocysteine","volume":"136","author":"Lim","year":"2014","journal-title":"J Am Chem Soc"},{"issue":"4","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0390","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1021\/ja056726i","article-title":"Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers","volume":"128","author":"Hong","year":"2006","journal-title":"J Am Chem Soc"},{"issue":"35","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0395","doi-asserted-by":"crossref","first-page":"29496","DOI":"10.1021\/acsami.7b07091","article-title":"GSH-activated NIR fluorescent prodrug for podophyllotoxin delivery","volume":"9","author":"Liu","year":"2017","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0400","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.actbio.2019.12.016","article-title":"ROS and GSH-responsive S-nitrosoglutathione functionalized polymeric nanoparticles to overcome multidrug resistance in cancer","volume":"103","author":"Wu","year":"2020","journal-title":"Acta Biomater"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0405","doi-asserted-by":"crossref","first-page":"119666","DOI":"10.1016\/j.biomaterials.2019.119666","article-title":"An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy","volume":"230","author":"Lu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-99873-4.00022-0_bb0410","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jconrel.2020.01.003","article-title":"Self-assembling and self-formulating prodrug hydrogelator extends survival in a glioblastoma resection and recurrence model","volume":"319","author":"Schiapparelli","year":"2020","journal-title":"J Control Release"},{"issue":"10","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0415","doi-asserted-by":"crossref","first-page":"12143","DOI":"10.1021\/acsami.0c00509","article-title":"Angiopep2-conjugated star-shaped polyprodrug amphiphiles for simultaneous glioma-targeting therapy and MR imaging","volume":"12","author":"Wang","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0420","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1021\/acsnano.0c09115","article-title":"Harnessing endogenous stimuli for responsive materials in theranostics","volume":"15","author":"Cook","year":"2021","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0425","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1021\/acsnano.9b00300","article-title":"A Mn(III)-sealed metal-organic framework nanosystem for redox-unlocked tumor theranostics","volume":"13","author":"Wan","year":"2019","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0430","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1039\/C5TB02490K","article-title":"MMP-responsive theranostic nanoplatform based on mesoporous silica nanoparticles for tumor imaging and targeted drug delivery","volume":"4","author":"Hu","year":"2016","journal-title":"J Mater Chem B"},{"issue":"4","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0435","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1021\/acsnano.0c02197","article-title":"Supramolecular aggregation-induced emission nanodots with programmed tumor microenvironment responsiveness for image-guided orthotopic pancreatic Cancer therapy","volume":"14","author":"Chen","year":"2020","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0440","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1158\/1535-7163.MCT-17-0022","article-title":"A novel theranostic strategy for MMP-14-expressing glioblastomas impacts survival","volume":"16","author":"Mohanty","year":"2017","journal-title":"Mol Cancer Ther"},{"issue":"21","key":"10.1016\/B978-0-323-99873-4.00022-0_bb0445","doi-asserted-by":"crossref","first-page":"9487","DOI":"10.1039\/C5NR01408E","article-title":"Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma","volume":"7","author":"Ruan","year":"2015","journal-title":"Nanoscale"}],"container-title":["New Insights Into Glioblastoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323998734000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323998734000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T16:43:27Z","timestamp":1756485807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780323998734000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780323998734"],"references-count":88,"URL":"https:\/\/doi.org\/10.1016\/b978-0-323-99873-4.00022-0","relation":{},"subject":[],"published":{"date-parts":[[2023]]}}}